BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Clinical Outcome
4 results:

  • 1. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
    Suwala AK; Stichel D; Schrimpf D; Kloor M; Wefers AK; Reinhardt A; Maas SLN; Kratz CP; Schweizer L; Hasselblatt M; Snuderl M; Abedalthagafi MSJ; Abdullaev Z; Monoranu CM; Bergmann M; Pekrun A; Freyschlag C; Aronica E; Kramm CM; Hinz F; Sievers P; Korshunov A; Kool M; Pfister SM; Sturm D; Jones DTW; Wick W; Unterberg A; Hartmann C; Dodgshun A; Tabori U; Wesseling P; Sahm F; von Deimling A; Reuss DE
    Acta Neuropathol; 2021 Jan; 141(1):85-100. PubMed ID: 33216206
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Promoter methylation of AREG, HOXA11, hmlh1, NDRG2, NPTX2 and Tes genes in glioblastoma.
    Skiriutė D; Vaitkienė P; Ašmonienė V; Steponaitis G; Deltuva VP; Tamašauskas A
    J Neurooncol; 2013 Jul; 113(3):441-9. PubMed ID: 23624749
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Immunohistochemical and molecular analyis of mismatch repair genes in germ cell tumors].
    Velasco Palma A; Riquelme Sánchez E; Schulze Maroto M; Villarroel del Pino L; Leach FS
    Actas Urol Esp; 2005 Feb; 29(2):198-206. PubMed ID: 15881919
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Promoter hypermethylation of mismatch repair gene hmlh1 predicts the clinical response of malignant astrocytomas to nitrosourea.
    Fukushima T; Katayama Y; Watanabe T; Yoshino A; Ogino A; Ohta T; Komine C
    Clin Cancer Res; 2005 Feb; 11(4):1539-44. PubMed ID: 15746058
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.